This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Citrix Systems, Watson Pharmaceuticals: S&P Gainers

Stock quotes in this article: CTXS, ^GSPC, WPI

NEW YORK ( TheStreet) -- Citrix Systems (CTXS) and Watson Pharmaceuticals (WPI) were among the best-performing stocks in the S&P 500 on Thursday.

The S&P 500 rose 9.29 points, or 0.67%, to 1,399.98 on Thursday.

Shares of Citrix Systems gained 12.43% to $86.76. On Thursday, the stock was upgraded to outperform by FBR Securities analysts with a $100 price target after a big earnings beat.

The company reported Wednesday after the close first-quarter earnings of 59 cents a share, excluding items, up from year-earlier earnings of 50 cents. On average, analysts expected earnings of 51 cents a share.

First quarter revenue grew 20% to $589 million.

Citrix Systems trades at an estimated price-to-earnings ratio for next year of 27.37X; the average for software companies is 30.58X. For comparison, Salesforce.com (CRM) has a higher forward P/E of 74.88X.

Twenty-three of the 35 analysts who cover Citrix rated it buy. Eleven analysts gave the stock a hold rating and one rated it sell.

TheStreet Ratings gives Citrix an A- grade with a buy rating and $90.32 price target. The stock has risen 42.89% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,766.43 -38.28 -0.23%
S&P 500 1,937.81 -8.35 -0.43%
NASDAQ 4,407.2870 -14.7980 -0.33%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs